KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Assets (2016 - 2025)

LifeMD's Assets history spans 14 years, with the latest figure at $70.4 million for Q4 2025.

  • For Q4 2025, Assets fell 7.47% year-over-year to $70.4 million; the TTM value through Dec 2025 reached $70.4 million, down 7.47%, while the annual FY2025 figure was $70.4 million, 7.47% down from the prior year.
  • Assets reached $70.4 million in Q4 2025 per LFMD's latest filing, up from $66.0 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $76.1 million in Q4 2024 to a low of $16.4 million in Q3 2021.
  • Average Assets over 5 years is $47.9 million, with a median of $45.3 million recorded in 2021.
  • Peak YoY movement for Assets: surged 718.13% in 2021, then tumbled 48.59% in 2022.
  • A 5-year view of Assets shows it stood at $49.9 million in 2021, then tumbled by 48.59% to $25.7 million in 2022, then soared by 127.85% to $58.5 million in 2023, then soared by 30.12% to $76.1 million in 2024, then decreased by 7.47% to $70.4 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Assets are $70.4 million (Q4 2025), $66.0 million (Q3 2025), and $73.6 million (Q2 2025).